台灣臨床試驗主持人資料庫|TPIDB

2013-09-01 - 2016-06-21

Phase III

A Randomized, Open-label Phase 3 Study of Carfilzomib, Melphalan, and Prednisone versus Bortezomib, Melphalan, and Prednisone in Transplant-ineligible Patients with Newly Diagnosed Multiple Myeloma

Condition/Disease

Multiple Myeloma
Test Drug

Carfilzomib

Participate Sites
6Sites

Terminated5Sites

Study ended1Sites

葉士芃

China Medical University Hospital

Division of Hematology & Oncology

2014-12-01 - 2018-06-30

Phase II

A Randomized Phase 2A/2B, Multicenter Study to Compare the Efficacy and Safety of ASLAN001 in Combination with Capecitabine to Lapatinib in Combination with Capecitabine in Patients with HER-2-Positive Metastatic Breast Cancer that has Failed on Prior Trastuzumab Therapy

Condition/Disease

Breast Cancer
Test Drug

ASLAN001

Participate Sites
7Sites

Terminated6Sites

Study ended1Sites

王惠暢

China Medical University Hospital

Division of General Surgery

2016-09-01 - 2019-01-31

Phase III

A Randomized, Double-Blind, Parallel-Group, Placebo- and Active-Controlled, Multicenter Phase III Study of the Efficacy and Safety of Olokizumab in Subjects with Moderately to Severely Active Rheumatoid Arthritis Inadequately Controlled by Methotrexate Therapy

Condition/Disease

Rheumatoid Arthritis
Test Drug

Olokizumab

Participate Sites
5Sites

Terminated3Sites

Study ended1Sites

黃春明

China Medical University Hospital

2013-04-01 - 2022-12-05

Phase IV

A Randomized, Double-Blind, Placebo-Controlled 52-Week Study to Assess Adverse Events of Special Interest in Adults with Active, AutoantibodyPositive Systemic Lupus Erythematosus Receiving Belimumab

Condition/Disease

Systemic Lupus Erythematosus
Test Drug

BENLYSTA (Belimumab)

Participate Sites
8Sites

Recruiting1Sites

Terminated7Sites

黃春明

China Medical University Hospital

2012-01-05 - 2013-06-30

Phase III

A phase 3, multicenter, randomized, double-blind, placebo-controlled Trial of Fixed-dose OPC-34712 (4,2, and 1 mg/day) in the Treatment of Adults With Acute Schizophrenia

Condition/Disease

Schizophrenia
Test Drug

OPC-34712

Participate Sites
4Sites

Terminated4Sites

藍先元

China Medical University Hospital

Division of Psychiatry

2012-03-30 - 2014-06-30

Phase III

A phase 3, Multicenter, Open-label trial to evaluate the Safety and Tolerability of Oral OPC-34712 as Maintenance Treatment in Adults with Schizophrenia

Condition/Disease

Schizophrenia
Test Drug

OPC-34712

Participate Sites
4Sites

Terminated4Sites

藍先元

China Medical University Hospital

Division of Psychiatry

2013-12-18 - 2015-10-31

Phase III

A Multicenter, Randomized, Double-blind Trial to Assess the Efficacy and Safety of ASC-01 in Patients with Major Depressive Disorder

Condition/Disease

Major depressive disorder
Test Drug

ASC-01

Participate Sites
12Sites

Terminated12Sites

藍先元

China Medical University Hospital

Division of Psychiatry

2020-02-01 - 2021-09-15

Phase III

A Phase 3, randomized, double-blind, placebo-controlled study evaluating efficacy and safety of rozanolixizumab in adult patients with generalized myasthenia gravis.

Condition/Disease

generalized myasthenia gravis
Test Drug

Rozanolixizumab

Participate Sites
5Sites

Recruiting5Sites

郭育呈

China Medical University Hospital

Division of Neurology

2014-11-03 - 2016-11-01

Phase II

A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF AC 201 IN SUBJECTS WITH GOUT

Condition/Disease

Osteoarthritis
Test Drug

AC-201

Participate Sites
8Sites

Terminated7Sites

Study ended1Sites

黃春明

China Medical University Hospital

Division of Rheumatology

2013-01-01 - 2015-12-31

Phase III

Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 12-Month Trial of Leuco-methylthioninium bis(hydromethanesulfonate) in Subjects with Mild to Moderate Alzheimer's Disease

Condition/Disease

Alzeheimer's Disease
Test Drug

LMTM

Participate Sites
6Sites

Terminated5Sites

Study ended1Sites

楊玉婉

China Medical University Hospital

Division of Neurology

Search Result

List